China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Role of Inflammatory Cytokines in the Mechanism by Which tDCS Ameliorates Cognitive Impairment Following MECT in Schizophrenia'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132129
Registration Time: 2026/09/09
Type: Interventional study
Primary Sponsor: The Affiliated Kangning Hospital of Ningbo University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341864
Published by HT Digital Content Services with permission from Health Daily Digest....